How to Export Pharmaceuticals from the U.S.

Exporting pharmaceuticals from the United States is governed by three overlapping rulebooks: FDA rules on what drugs may leave the country, DEA rules for controlled substances, and the same export-control and filing framework that applies to any U.S. export. Which rules bite hardest depends on the product — an FDA-approved over-the-counter medicine, an unapproved investigational drug, and a Schedule II narcotic each take a different path out of the country.

FDA: Approved vs. Unapproved Drugs

The Federal Food, Drug, and Cosmetic Act (FD&C Act) draws the key line.

A drug that is approved for U.S. marketing can generally be exported like other regulated goods, subject to the destination country’s own registration and import rules.

A drug that is not approved in the United States can still be exported, but only under conditions. Section 802 of the FD&C Act permits export of an unapproved human drug if it has valid marketing authorization in a listed country — Australia, Canada, Israel, Japan, New Zealand, Switzerland, South Africa, or a country in the EU/EEA — and meets the statute’s conditions. Alternatively, Section 801(e)(1) allows export of an unapproved drug when it accords to the specifications of the foreign buyer, is not in conflict with the importing country’s laws, is labeled for export, and is not sold or offered for sale in the U.S. Exporters often support shipments with an FDA Certificate of Pharmaceutical Product (CPP) or export certificate, which the destination’s regulator may require, and certain exports require notification to FDA.

DEA: Controlled Substances Are a Separate Track

If the product is a controlled substance, FDA compliance is not enough — the Drug Enforcement Administration regulates it under the Controlled Substances Act (21 CFR Part 1312). The exporter must be registered with DEA, and a separate permit or declaration is required for each shipment:

Higher-schedule narcotics generally require an export permit (Form 161), while certain lower-schedule substances may move on a declaration (Form 236). DEA also typically wants the importing country’s authorization confirming it will admit the shipment. Build DEA lead time into the schedule — these approvals are not instant.

The Standard Export Layer Still Applies

On top of FDA and DEA, the ordinary export rules run in the background. Classify the product (most finished drugs are EAR99, but precursors and certain technologies can be controlled), screen the buyer and consignee against the denied- and blocked-party lists, confirm the destination is not embargoed, and file your Electronic Export Information when the value under a single classification exceeds $2,500 or a license is required. Cold-chain products add a quality layer: good distribution practices, validated temperature control, and documentation that the chain held.

A Sequenced Approach

1. Classify the product — approved vs. unapproved drug; controlled substance or not.
2. Clear the FDA path — direct export for approved drugs; Section 802 or 801(e)(1) conditions for unapproved drugs; obtain a CPP/export certificate if the destination needs one.
3. Clear DEA — register and file Form 161 or 236 per shipment for controlled substances, with destination authorization.
4. Confirm destination registration — the importing country’s drug regulator sets its own admission rules.
5. Run the export layer — classification, screening, EEI filing, and recordkeeping.

Frequently Asked Questions

Can I export a drug that isn’t approved in the United States?

Often yes, but only under the FD&C Act’s conditions. Section 802 allows export when the drug has marketing authorization in a listed country and meets the statute’s requirements; Section 801(e)(1) allows export when the drug meets the foreign buyer’s specifications, complies with the destination’s law, is labeled for export, and is not sold in the U.S.

What does the DEA require to export a controlled substance?

DEA registration plus a per-shipment permit (Form 161) or declaration (Form 236) under 21 CFR Part 1312, generally with confirmation that the importing country will admit the shipment.

Do export-control and EEI rules apply to drugs?

Yes. Drugs are subject to the EAR like other goods (most finished products are EAR99), so you still screen parties and destinations and file EEI when the value threshold or a license requirement is triggered.

What is a Certificate of Pharmaceutical Product?

A CPP is an FDA-issued export certificate, in a World Health Organization-recognized format, that a destination country’s regulator may require to register or admit the product. FDA also issues other export certificates depending on the product and market.

The penalties for an out-of-bounds pharmaceutical export are severe, and the FDA and DEA tracks rarely align on their own. Reidel Law Firm helps drug and device exporters map the FDA, DEA, and export-control requirements for each product and market on flat-fee terms. Get an export compliance memo.